Search Within

Malcolm A S Moore

  1. "John Crown"
Formats
  1. Meeting Abstract (6)
  2. Journal Article (4)
Groups
  1. Cell Biology Program Faculty (10)
  2. Department of Medicine (10)
  3. Hematologic Malignancies, Division of (10)
  4. Sloan Kettering Institute Faculty (10)
  5. Solid Tumor Oncology Division (10)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (9)

More Groups

People
  1. John Crown (10)
  2. Jeffrey Schneider (9)
  3. Larry Norton (9)
  4. Lilian Reich (9)
  5. David Fennelly (7)
  6. Fred Shapiro (5)

More People

Years
  1. 1995 (2)
  2. 1994 (4)
  3. 1993 (2)
  4. 1992 (1)
  5. 1991 (1)
Publications
  1. Blood (5)
  2. Cancer (1)
  3. Gynecologic Oncology (1)
  4. JNCI: Journal of the National Cancer Institute (1)
  5. Journal of Clinical Oncology (1)
  6. Proceedings of the American Association for Cancer Research Annual Meeting (1)
Publishers
  1. American Society of Hematology (5)
  2. American Association for Cancer Research (1)
  3. American Society of Clinical Oncology (1)
  4. Elsevier B.V. (1)
  5. Oxford University Press (1)
  6. Wiley Blackwell (1)

Results (10)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Rapid hematologic recovery following CD34+ selected versus unselected peripheral blood progenitor cell (PBPC) plus filgrastim (G) rescue of sequential high dose chemotherapy (HDC) in patients (PTS) with metastatic breast cancer (MBC)
    Meeting Abstract

    Raptis, G.; Tiersten, A.; Shapiro, F.; Schneider, J.; Hamilton, N.; Reich, L.; Wuest, D.; Gucciardo, A.; Quiguyan, L.; Gilewski, T.; more...
    Blood (1995)

    Fulltext@MSK | Save
  • Dose escalation of paclitaxel with high-dose cyclophosphamide, with analysis of progenitor-cell mobilization and hematologic support of advanced ovarian cancer patients receiving rapidly sequenced high-dose carboplatin/cyclophosphamide courses
    Journal Article

    Fennelly, D.; Schneider, J.; Spriggs, D.; Bengala, C.; Hakes, T.; Reich, L.; Barakat, R.; Curtin, J.; Moore, M. A. S.; Hoskins, W.; more...
    Journal of Clinical Oncology (1995)

    Fulltext@MSK | Save
  • Taxol in combination with cyclophosphamide and GCSF, a novel peripheral blood progenitor cell mobilizing regimen
    Meeting Abstract

    Fennelly, D.; Bengala, C.; Schneider, J.; Hakes, T.; Spriggs, D.; Reich, L.; Yao, T. J.; Shapiro, F.; Norton, L.; Moore, M. A. S.; more...
    Proceedings of the American Association for Cancer Research Annual Meeting (1994)

    Fulltext@MSK | Save
  • Treatment of advanced ovarian cancer (AOC) with high-dose (HD) carboplatin (C) and escalating-dose taxol (TXL) with cyclophosphamide (CTX)/TXL-primed peripheral blood progenitor cells (PBP) as hematological support (HS): A phase I study
    Meeting Abstract

    Fennelly, D.; Schneider, J.; Hakes, T.; Crown, J.; Bengala, C.; Reich, L.; Moore, M.; Gulati, S.; Shapiro, F.; Barakat, R.; more...
    Gynecologic Oncology (1994)

    Fulltext@MSK | Save
  • Peripheral blood progenitor cell (PBP) mobilization using Taxol (T) in combination with cyclophosphamide (C) and GCSF; Quantitation and correlation of CD34+ cell count, colony-forming-unit granulocyte-macrophage (CFU-GM), and mononuclear cell (MNC) count
    Meeting Abstract

    Fennelly, D.; Bengala, C.; Schneider, J.; Reich, L.; Norton, L.; Spriggs, D.; Moore, M. A. S.; Crown, J.
    Blood (1994)

    Fulltext@MSK | Save
  • Comparative efficacy of bone marrow engraftment following high-dose (HD) carboplatin (CBDCA) plus cyclophosphamide versus high-dose CBDCA/Taxol (TXL), when rescued with TXL cyclophosphamide (CPA) and GCSF mobilized peripheral blood progenitor cells (PBP)
    Meeting Abstract

    Fennelly, D.; Shapiro, F.; Schneider, J.; Spriggs, D.; Bengala, C.; McKenzie, M.; Reich, L.; Norton, L.; Moore, M. A. S.; Crown, J.
    Blood (1994)

    Fulltext@MSK | Save
  • Taxol (TXL) in combination with cyclophosphamide (CTX) and G-CSF can improve the mobilization of peripheral blood progenitors cells (PBPCs) in untreated locally advanced ovarian cancer: Preliminary report
    Meeting Abstract

    Bengala, C.; Fennelly, D.; Shapiro, F.; Schneider, J.; Reich, L.; Moore, M. A. S.; Norton, L.; Crown, J.
    Blood (1993)

    Fulltext@MSK | Save
  • Beneficial impact of peripheral blood progenitor cells in patients with metastatic breast cancer treated with high‐dose chemotherapy plus granulocyte‐macrophage colony‐stimulating factor: A randomized trial
    Journal Article

    Kritz, A.; Crown, J. P.; Motzer, R. J.; Reich, L. M.; Heller, G.; Moore, M. P.; Hamilton, N.; Yao, T. J.; Heelan, R. T.; Schneider, J. G.; more...
    Cancer (1993)

    Fulltext@MSK | Save
  • Rapid delivery of multiple high-dose chemotherapy courses with granulocyte colony-stimulating factor and peripheral blood-derived hematopoietic progenitor cells
    Journal Article

    Crown, J.; Wassherheit, C.; Hakes, T.; Fennelly, D.; Reich, L.; Moore, M.; Schneider, J.; Curtin, J.; Rubin, S. C.; Reichman, B.; more...
    JNCI: Journal of the National Cancer Institute (1992)

    Fulltext@MSK | Save
  • A phase I trial of recombinant human interleukin-1β alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancer
    Journal Article

    Crown, J.; Jakubowski, A.; Kemeny, N.; Gordon, M.; Gasparetto, C.; Wong, G.; Sheridan, C.; Toner, G.; Meisenberg, B.; Botet, J.; more...
    Blood (1991)

    Fulltext@MSK | Save